Translational/personalized medicine, pharmaco/surgico/radiogenomics, lymphatic spread of cancer, and medical ignoromes

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

In the elusive quest for "personalized" cancer treatments based on pharmacogenomics, diverse challenges must be overcome: questionable validity of "molecular models of life," obstacles to bidirectional translation of scientific advances from bench to bedside to community, and limitations of bioinformatics to recognize and deal with "ignoramics/ignoromes" (expanding unknowns in cancer biology, theranostics, and therapeutic choices). These considerations apply to lymphatic system functioning-lymphatic vessels, lymph, lymph nodes, and lymphocytes-in diseases like cancer.

Original languageEnglish (US)
Pages (from-to)501-507
Number of pages7
JournalJournal of Surgical Oncology
Volume103
Issue number6
DOIs
StatePublished - May 1 2011

Keywords

  • ignoramics
  • lymphology
  • personalized medicine
  • pharmacogenomics
  • surgicogenomics
  • translation

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Translational/personalized medicine, pharmaco/surgico/radiogenomics, lymphatic spread of cancer, and medical ignoromes'. Together they form a unique fingerprint.

  • Cite this